Egr-2 and Egr-3 are negative regulators of T cell activation

被引:333
作者
Safford, M
Collins, S
Lutz, MA
Allen, A
Huang, CT
Kowalski, J
Blackford, A
Horton, MR
Drake, C
Schwartz, RH
Powell, JD [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Care Ctr, Baltimore, MD 21205 USA
[2] Chang Gung Univ, Sch Med & Hosp, Taipei, Taiwan
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[4] NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1038/ni1193
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell receptor engagement in the absence of proper accessory signals leads to T cell anergy. E3 ligases are involved in maintaining the anergic state. However, the specific molecules responsible for the induction of anergy have yet to be elucidated. Using microarray analysis we have identified here early growth response gene 2 (Egr- 2) and Egr- 3 as key negative regulators of T cell activation. Overexpression of Egr2 and Egr3 was associated with an increase in the E3 ubiquitin ligase Cbl-b and inhibition of T cell activation. Conversely, T cells from Egr3(-/-) mice had lower expression of Cbl-b and were resistant to in vivo peptide-induced tolerance. These data support the idea that Egr-2 and Egr-3 are involved in promoting a T cell receptor-induced negative regulatory genetic program.
引用
收藏
页码:472 / 480
页数:9
相关论文
共 33 条
[1]   In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions [J].
Adler, AJ ;
Huang, CT ;
Yochum, GS ;
Marsh, DW ;
Pardoll, DM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :649-655
[2]   The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells [J].
Decker, EL ;
Skerka, C ;
Zipfel, PF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) :26923-26930
[3]   Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation [J].
Diehn, M ;
Alizadeh, AA ;
Rando, OJ ;
Liu, CL ;
Stankunas, K ;
Botstein, D ;
Crabtree, GR ;
Brown, PO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11796-11801
[4]   How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis [J].
Glynne, R ;
Akkaraju, S ;
Healy, JI ;
Rayner, J ;
Goodnow, CC ;
Mack, DH .
NATURE, 2000, 403 (6770) :672-676
[5]   NONDELETIONAL MECHANISMS OF PERIPHERAL AND CENTRAL TOLERANCE - STUDIES WITH TRANSGENIC MICE WITH TISSUE-SPECIFIC EXPRESSION OF A FOREIGN MHC CLASS-I ANTIGEN [J].
HAMMERLING, GJ ;
SCHONRICH, G ;
MOMBURG, F ;
AUPHAN, N ;
MALISSEN, M ;
MALISSEN, B ;
SCHMITTVERHULST, AM ;
ARNOLD, B .
IMMUNOLOGICAL REVIEWS, 1991, 122 :47-67
[6]   Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells [J].
Harris, JE ;
Bishop, KD ;
Phillips, NE ;
Mordes, JP ;
Greiner, DL ;
Rossini, AA ;
Czech, MP .
JOURNAL OF IMMUNOLOGY, 2004, 173 (12) :7331-7338
[7]   Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins [J].
Heissmeyer, V ;
Macián, F ;
Im, SH ;
Varma, R ;
Feske, S ;
Venuprasad, K ;
Gu, H ;
Liu, YC ;
Dustin, ML ;
Rao, A .
NATURE IMMUNOLOGY, 2004, 5 (03) :255-265
[8]   CD4+ T cells pass through an effector phase during the process of in vivo tolerance induction [J].
Huang, CT ;
Huso, DL ;
Lu, ZB ;
Wang, TH ;
Zhou, G ;
Kennedy, EP ;
Drake, CG ;
Morgan, DJ ;
Sherman, LA ;
Higgins, AD ;
Pardoll, DM ;
Adler, AJ .
JOURNAL OF IMMUNOLOGY, 2003, 170 (08) :3945-3953
[9]   Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction [J].
Jeon, MS ;
Atfield, A ;
Venuprasad, K ;
Krawczyk, C ;
Sarao, R ;
Elly, C ;
Yang, C ;
Arya, S ;
Bachmaier, K ;
Su, L ;
Bouchard, D ;
Jones, R ;
Gronski, M ;
Ohashi, P ;
Wada, T ;
Bloom, D ;
Fathman, CG ;
Liu, YC ;
Penninger, JM .
IMMUNITY, 2004, 21 (02) :167-177
[10]   THYMIC SELECTION OF CD8+ SINGLE POSITIVE CELLS WITH A CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED RECEPTOR [J].
KIRBERG, J ;
BARON, A ;
JAKOB, S ;
ROLINK, A ;
KARJALAINEN, K ;
VONBOEHMER, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :25-34